scholarly article | Q13442814 |
P50 | author | Gerald V Denis | Q55300538 |
Barbara Gilchrest | Q93373562 | ||
P2093 | author name string | Mark S Eller | |
Paul B Romesser | |||
Andrew M Rankin | |||
Douglas V Faller | |||
Harold O Longe | |||
P2860 | cites work | A biomarker that identifies senescent human cells in culture and in aging skin in vivo | Q24562644 |
The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2 | Q28116237 | ||
p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2 | Q28609749 | ||
Enhanced phosphorylation of p53 by ATM in response to DNA damage | Q28609838 | ||
Stimulation of melanogenesis by DNA oligonucleotides: effect of size, sequence and 5' phosphorylation | Q31871227 | ||
Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. | Q32061783 | ||
Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. | Q33642188 | ||
E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. | Q33673921 | ||
Evidence that exposure of the telomere 3' overhang sequence induces senescence | Q34470102 | ||
A role for WRN in telomere-based DNA damage responses | Q35062281 | ||
DNA damage induces phosphorylation of the amino terminus of p53 | Q35199554 | ||
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells | Q35749321 | ||
Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids | Q35847527 | ||
Treatment of diffuse large B-cell lymphoma | Q35989669 | ||
The tale of the telomere: implications for prevention and treatment of skin cancers | Q36346181 | ||
Telomere and adaptive immunity | Q36511640 | ||
Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. | Q36576646 | ||
Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway | Q36929159 | ||
Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. | Q37095361 | ||
Induction of apoptosis by telomere 3' overhang-specific DNA. | Q38288992 | ||
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides | Q38334543 | ||
Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. | Q38358265 | ||
Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells | Q40203284 | ||
Nuclease resistance of telomere-like oligonucleotides monitored in live cells by fluorescence anisotropy imaging | Q40311165 | ||
Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines | Q40371789 | ||
Telomere-based DNA damage responses: a new approach to melanoma | Q40521591 | ||
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349). | Q40578618 | ||
Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. | Q40902679 | ||
Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines | Q42811736 | ||
CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals | Q44259068 | ||
Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development | Q46153870 | ||
Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin's lymphoma cell lines. | Q47929473 | ||
Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells | Q48193623 | ||
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. | Q52828546 | ||
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes | Q52833019 | ||
The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. | Q54023509 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 473-482 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential | |
P478 | volume | 124 |
Q42176144 | Alternative strategy for Alzheimer's disease: stress response triggers |
Q38819605 | Beyond Telomerase: Telomere Instability as a Novel Target for Cancer Therapy |
Q33642463 | Brd2 disruption in mice causes severe obesity without Type 2 diabetes |
Q34513460 | Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation |
Q37146556 | Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancer |
Q38324478 | Cytotoxic effects and specific gene expression alterations induced by I-125-labeled triplex-forming oligonucleotides. |
Q58579018 | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
Q37139643 | Enhanced cytotoxicity from deoxyguanosine-enriched T-oligo in prostate cancer cells. |
Q37619108 | Epstein-Barr virus and telomerase: from cell immortalization to therapy |
Q39023825 | Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth |
Q42105603 | Inhibition of melanoma angiogenesis by telomere homolog oligonucleotides |
Q30497657 | Intracellular Traffic of Oligodeoxynucleotides In and Out of the Nucleus: Effect of Exportins and DNA Structure |
Q37093551 | Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma |
Q35652897 | Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells |
Q39095019 | Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides |
Q58696640 | Oligonucleotides Targeting Telomeres and Telomerase in Cancer |
Q34989021 | Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment. |
Q36299184 | Site specific replacements of a single loop nucleoside with a dibenzyl linker may switch the activity of TBA from anticoagulant to antiproliferative |
Q38305253 | Star-shaped tetraspermine enhances cellular uptake and cytotoxicity of T-oligo in prostate cancer cells |
Q89597527 | Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations |
Q36643420 | Suppressive oligodeoxynucleotides synergistically enhance antiproliferative effects of anticancer drugs in A549 human lung cancer cells |
Q35121429 | T-oligo as an anticancer agent in colorectal cancer |
Q35048659 | T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells |
Q35784732 | Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition? |
Q36862798 | Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis |
Q28487756 | The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity |
Q38288984 | Treating Cancer by Targeting Telomeres and Telomerase |
Q38310060 | hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang |
Search more.